Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

PUBLISHED: November 29, 2022

PAGES: 94 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

GlobalData's Medical Devices sector report, "Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Structural Heart Occluders pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Structural heart occluders are used for treatment congenital heart defects by closing openings in the heart. Structural heart occluders covers left atrial appendage closure devices, atrial septal defect occluders, ventricular septal defect occluders, patent foramen ovale closure devices, patent ductus arteriosus closure devices.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Structural Heart Occluders under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Structural Heart Occluders and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Structural Heart Occluders under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Product Code: GDME1476EPD

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Structural Heart Occluders Overview

3 Products under Development

3.1 Structural Heart Occluders - Pipeline Products by Stage of Development
3.2 Structural Heart Occluders - Pipeline Products by Segment
3.3 Structural Heart Occluders - Pipeline Products by Territory
3.4 Structural Heart Occluders - Pipeline Products by Regulatory Path
3.5 Structural Heart Occluders - Pipeline Products by Estimated Approval Date
3.6 Structural Heart Occluders - Ongoing Clinical Trials

4 Structural Heart Occluders - Pipeline Products under Development by Companies

4.1 Structural Heart Occluders Companies - Pipeline Products by Stage of Development
4.2 Structural Heart Occluders - Pipeline Products by Stage of Development

5 Structural Heart Occluders Companies and Product Overview

5.1 Aegis Medical Innovations Inc. Company Overview
5.2 Aporo Biomedical, Inc. (Inactive) Company Overview
5.3 Append Medical Company Overview
5.4 atHeart Medical Company Overview
5.5 AuriGen Medical Ltd Company Overview
5.6 Boston Scientific Corp Company Overview
5.7 CARAG AG Company Overview
5.8 Cierra, Inc. (Inactive) Company Overview
5.9 Conformal Medical Inc Company Overview
5.10 Cor Habere Corp Company Overview
5.11 Dextera Surgical Inc Company Overview
5.12 Ension, Inc. Company Overview
5.13 Guangdong Pulse Medical Technology Co Ltd Company Overview
5.14 Hangzhou Dinova EP Technology Co Ltd Company Overview
5.15 Hansen Medical Inc (Inactive) Company Overview
5.16 Laminar Inc Company Overview
5.17 Lepu Scientech Medical Technology (Shanghai) Co Ltd Company Overview
5.18 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.19 LuSeed Vascular Company Overview
5.20 Mayo Clinic Company Overview
5.21 Medtronic Plc Company Overview
5.22 Meril Life Sciences Pvt Ltd Company Overview
5.23 Micro Interventional Devices, Inc. Company Overview
5.24 MicroPort Scientific Corp Company Overview
5.25 Northwestern University Company Overview
5.26 Occlutech International AB Company Overview
5.27 SentreHEART Inc Company Overview
5.28 SeptRx, Inc. (Inactive) Company Overview
5.29 Shanghai Shenqi Medical Technology Co Ltd Company Overview
5.30 Swissimplant AG Company Overview
5.31 The Chaim Sheba Medical Center Company Overview
5.32 University of Minnesota Company Overview
5.33 Vascular Closure Systems Inc Company Overview
5.34 Vascular Concepts Ltd Company Overview
5.35 W. L. Gore & Associates Inc Company Overview

6 Appendix

6.1 Methodology
6.2 About GlobalData
6.3 Contact Us
6.4 Disclaimer

Product Code: GDME1476EPD

List of Tables

Structural Heart Occluders - Pipeline Products by Stage of Development
Structural Heart Occluders - Pipeline Products by Segment
Structural Heart Occluders - Pipeline Products by Territory
Structural Heart Occluders - Pipeline Products by Regulatory Path
Structural Heart Occluders - Pipeline Products by Estimated Approval Date
Structural Heart Occluders - Ongoing Clinical Trials
Structural Heart Occluders Companies - Pipeline Products by Stage of Development
Structural Heart Occluders - Pipeline Products by Stage of Development
Glossary